Spleen Australia. Immunisation for people with a non-functioning spleen. Vaccine schedules National and Victorian. 29 th July 2017

Size: px
Start display at page:

Download "Spleen Australia. Immunisation for people with a non-functioning spleen. Vaccine schedules National and Victorian. 29 th July 2017"

Transcription

1 Spleen Australia Immunisation for people with a non-functioning spleen. Vaccine schedules National and Victorian Penelope Jones RN Grad Dip Epi Manager Spleen Australia 29 th July 2017

2 Meningococcal W Spleen room pin board Capnocytophaga canimorsus SunHerald 03/01/2007 Strep pneumoniae

3 Outline Cases Why a Clinical Registry Recommendations Summary numbers Take home messages

4 Case 1-40 year old man husband and father of 3 young boys 24hr history of lethargy, chills Collapse at home Ambulance - Cardiac arrest Admission Alfred CPR, adrenalin, IV fluids, antibiotics shock, cyanosed, unreactive pupils Intubated, inotropes, vasopressin, antibiotics Dead within 5 hours of admission

5 Case 1 - Intensive Care Purpura fulminans fatal thrombotic disorder bruising, blood spots associated with DIC

6 Investigations Blood cultures x 3 - negative at 24hrs Blood film - diplococci in neutrophils and Howell Jolly Bodies Blood - positive PCR Streptococcus pneumoniae Further history Case 1 continued Splenectomy for trauma 20 yrs prior No preventive measures

7 Case 1 Blood Film: positive PCR Streptococcus pneumoniae Diplococci bacteria within neutrophils Howell-Jolly Bodies in the erythrocytes

8 1 Case 2-6 year old girl Coroner s report June 2013 Admitted to QLD Hospital referred by GP Was known to have had a splenectomy (HS)?Viral infection no one seems to have seriously considered that Lilli was also at risk of developing an OPSI No blood cultures done in early admission Late reaction to results of bacterial sepsis SYSTEM FAILURE where action could have been taken earlier, which may have prevented her death occurring.

9 Case 3 Father of 6 children & husband quadruple amputations following severe pneumococcal sepsis **Hospitalised for 7 months** Concord Hospital NSW 49 year old male Cost >$300K (Hospital admission)

10 Background phagocytes remove encapsulated bacteria Pneumococcal & meningococcal *Streptococcus pneumoniae Blood film Neisseria meningitidis Others Haemophilus Influenzae Group B streptococcus Capnocytophaga canimorsus

11 Background Identifying people with asplenia/hyposplenism 1. History of operation 2. Howell-Jolly Bodies on morphology

12 Splenic Artery Embolisation Spleen salvaging

13 Background Functions of the spleen FILTER Re-cycling of blood cells & removing RBCs (expiry ~120 days) Bacteria, viruses & toxic substances - filtered out of blood by WBCs IMMUNE SYSTEM / STORAGE Stores platelets and WBCs - monocytes Opsonization Largest unit of mononuclear phagocyte system (RES)

14 Background At time of pancreatectomy Gas Infections abscess in spleen

15 Background- Asplenia/hyposplenism Some medical conditions associated with hyposplenism Congenital cyanotic heart disease Coeliac Disease Sickle cell disease SLE Rheumatoid disease Splenic infarctions Splenic irradiation HIV infection Graft v Host Disease

16 Background Overwhelming Post Splenectomy Infection (OPSI) Risk difficult to quantify Estimates 3-5% lifetime risk * (1:20) 38-80% mortality * (morbidity?) Incidence % per year * Risk is considered high in first 2 years Case reports OPSI up to 30 yrs post splenectomy S.pneumoniae 50-90% of infections * Clin Micro Infect COST of OPSI ~ $50-$280K

17 Background Risk of sepsis (OPSI) varies Age young people more at risk Indication splenectomy (trauma v malignancies) Underlying medical conditions Lack of knowledge (of infection risk)!!

18 OPSI still occurring Best practice preventive strategies are known BUT Advice not given (medical staff unaware of risk/recent guidelines) Advice forgotten Quality of advice varies No reminders

19

20 Spleen Australia Clinical Service and Registry for people without a functioning spleen Case + Finding Registration Education Clinical Follow Up SPLEEN REGISTRY 7,051 Resource Development Research

21 Australia pop ~24 million Estimated 25,000 people with asplenia Or hyposplenism?? NZ collaboration Spleen Australia s collaborating states cover 10.3 million people

22 Annual referrals to Spleen Australia 10 Dec Dec QLD & Tas join 1000 Patient numbers Vic state funding Years

23 Ascertainment of cases No mandatory reporting what would it take? Anatomical pathologists Medical referrals (specialists, GPs) Medical records (Alfred/RMH) Opportunistic referrals Word of mouth (self referrals)

24 Resolve quandries (reassure) Liaise with GP Liaise with specialists/ hospitals Kit Reminders (Ongoing contact) Children and Adult Patients Travel advice NES *EDUCATE +/- relative VACCINES Confirm Sourcing ANTIBIOTICS

25 Spleen Australia s strategies for reducing sepsis Education Signs & symptoms of bacterial infection Alert cards Travel, animal bites, ticks, educate GPs Other pregnancy/breastfeeding, OCP or HRT Translated documents (Greek, Chinese, Arabic, Vietnamese) Vaccinations (Immunisation Handbook 10 th Edn) Pneumococcus Meningococcus Haemophilus Influenzae type b Annual influenza Antibiotics (Therapeutic Guidelines) Prophylaxis penicillin (allergic - roxithromycin) at least 3 years Emergency supply 3gm amoxycillin

26 Education kit items Spleen Australia

27 Extra items in kit for children

28 Sent to Patient Local doctor Referring doctor Specialists Treating hospital PLEASE enter the dates of vaccines the patient has received as per this report onto to GP immunisation history!

29 Reminders Annual newsletter & Apple device App

30 Invasive pneumococcal disease Epidemiology Strep. pneumoniae infection - major cause of VPD worldwide 90 strains of Streptococcus pneumoniae Nasopharynx of healthy carriers ,640 cases in Australia (7.2 cases per 100,000 pop) 6 times higher Indigenous Australians 23vPPV funded 65+ & Aboriginal & Torres Strait Islanders 50+ PREVENAR 13 (13 serotypes) PNEUMOVAX 23 (23 serotypes) (Pfizer) (Merck) 13vPCV 23vPPV

31 Invasive meningococcal disease Neisseria meningitidis 13 serogroups of N.meningitidis Six serogroups (A, B, C, W, X and Y) majority of cases worldwide 2002 to 2015 main serogroup in Australia was serogroup B Notifications of serogroup W (MenW) increased nearly 5-fold between 2014 and MenW main serogroup notified in Australia

32 Vaccines - types Polysaccharide eg. 23vPPV and 4vMenPV short term protection (few years) less immunogenic in children aged <2 Polysaccharide antigens induce antibodies without involvement of T-lymphocytes T-cell lymphocyte involvement necessary for long-term immune memory without it, protection short-lived and immunity wanes (?revaccination) Conjugate higher-quality & longer-term immunity, esp in children <2 years eg. Haemophilus influenzae type b - HIBERIX, PEDVAXHIB Neisseria meningitidis ( A, C, W135 & Y) - MENACTRA, MENVEO, NIMENRIX Streptococcus pneumoniae (13vPCV 19A & 6A) - SYNFLORIX & PREVENAR 13

33

34 NOT previously vaccinated Page 1 Hib if in doubt give Annual influenza 2 doses 4/52 apart if 1 st dose ever

35

36 Have had previous vaccines page 2

37

38 Paediatric medical recommendations

39 Medical recommendations for patients after Splenic artery embolisation Additional test - IgM memory B cells

40 Spleen Australia Database n= 7051 Splenectomy n = 6350 (90%) Functional Hyposplenism n = 315 (5%) Recommendations same as splenectomised patient Retained spleen function Splenic artery embolisation n=386 (5%) Spleen salvaging procedure >300 patients waitlisted (states not funding Registry)

41 Patients on database and reasons for referral n= No spleen function Spleen function

42 Children aged 0-18 years on database n= Number of patients male female Ages

43 Number of patients

44 Cost of Spleen Vaccines Private Chemists (initial doses and 8 week boosters) Pneumococcal Pneumo conjugate (Prevenar 13) $110 Pneumo polysaccharide (Pneumovax23) $36 (PBS) Meningococcal 4vMenCV (Menactra/Menveo) need 2 $160 MenB (Bexsero) need 2 $260 Haemophilus Influenzae Hib $36 (PBS) TOTAL ~$600 Hospital pharmacy costs as outpatient (except Men B) The PBS co-contribution price of $5.90 (health card) or $36.10 (no health card) **Free if an inpatient

45 Salient patient story in our 2015 newsletter

46 LESSONS LEARNED LEGAL ISSUE Australian Family Physician - June 2010 Dr Sara Bird Medico-legal and advisory unit, MDA Case: 42 yr unwell, mother of 3 children, presented to ED, MCA, no meds, no vaccinations, smoker +++ DIED after 30 mins of arrival in ED Family sued 1. Hospital - failed to vaccinate post op - educate and offer follow up 2. GP - failed to vaccinate - slow to diagnose IPD Settled out of court

47 Patients admitted to ICU with OPSI notified to Spleen Australia Sept/Oct 2016 Case Indication for splenectomy Years post splenectomy OPSI & serotype Vaccination Prophylaxis Mrs. MD Hereditary Spherocytosis 66 S. pneumoniae epidural abscess 23B Pneumovax 2004, 2010 Nil Mrs. JM 7581 Hereditary Spherocytosis 56 S. pneumoniae meningitis 23B Pneumovax 2002 Nil Mrs. HD Hodgkin Lymphoma 25 S. pneumoniae thoracic mycotic aneurysm 23B Unclear Nil Mr. BD Trauma 41 S. Pneumoniae infective endocarditis, septic arthritis 9N (23vPPV) Nil Nil

48 Does the spleen registry work? Rate of invasive pneumococcal and invasive meningococcal disease Pre-registration Post- registration 150 per 100,000 patient years 36 per 100,000 patient year Registration with Registry 69% reduction in risk of infection Incidence rate ratio 0.31, 95% CI: 0.12, 0.83 p= invasive infections prevented per year

49 Frequently asked questions We can answer them! 1. Zostavax see newsletter 2015 (YES if not immunosuppressed ) 2. Risk of meningococcal disease (see 2016 newsletter all newsletters on website) MenBV gaps b/n doses (not a concern but make sure 2 doses are given) Definitely give ACWY vaccines 3. Antibiotics lifelong in people >65yrs? (?probably) 4. Vaccine errors eg given out of order, given too soon, concern with chemo, multiple 23vPPV doses (you need our help!) 5. Cannot afford vaccines prioritising which ones 6. Flu shot quadrivalent & 2 doses if receiving for 1 st time 7. Travel advice (malaria) 8. DVT risk 9. Pregnancy/breastfeeding and vaccines (RWH ) 10. Intragam infusions & timing of vaccines

50 Take home messages Not having a spleen is a serious health issue Preventative measures work esp Educations, education, education Registration available if live in Vic, Tas & QLD If registered patient & health care providers have access to our support SPLEEN AUSTRALIA prevents OPSI spleenregistry@alfred.org.au

51

52 Acknowledgements Victoria, Tasmania and Queensland Departments of Health Immunisation nurses A/Prof Denis Spelman & Dr Ian Woolley Nurses: Julia McNamara, Nigel Pratt, Cate Bunn, Kate Wall Prof Allen Cheng & Prof Karin Leder (epidemiologists) Louise Grannell (pharmacist) A/Prof Jim Buttery & A/Prof Mike Starr & Nigel Crawford (Melb Paeds) Anatomical Pathologists BMedSci & medical students Participating patients (all unique!!) Alfred hospital s Dept of Infectious Diseases Alfred Health GPs & clinic nurses & hospital doctors who refer patients to us and follow up these vulnerable children and adult

If these vaccines haven t been given, please follow guidelines below for emergency procedures.

If these vaccines haven t been given, please follow guidelines below for emergency procedures. MANAGEMENT OF PATIIENTS POST SPLENECTOMY & HYPOSPLENIIC PATIIENTS Splenectomised and hyposplenic patients are at increased risk of life-threatening infections due to encapsulated micro-organisms such as

More information

Vaccination and prophylaxis for asplenia: Guideline for clinicians

Vaccination and prophylaxis for asplenia: Guideline for clinicians Vaccination and prophylaxis for asplenia: Guideline for clinicians Adults better health * better care * better value Acknowledgements The Western Australian Committee for Antimicrobials (WACA) would like

More information

BACTERIAL MENINGITIS IN CHILDREN

BACTERIAL MENINGITIS IN CHILDREN Overview Bacterial meningitis in children : rare, severe, mostly preventable What should GPs advise Australian parents in 2018? Peter McIntyre Professorial Fellow, National Centre for Immunisation Research

More information

Prevention of Overwhelming Postsplenectomy Infection in Adults

Prevention of Overwhelming Postsplenectomy Infection in Adults Prevention of Overwhelming Postsplenectomy Infection in Adults Introduction The spleen is the largest lymphatic organ in the body and its primary functions are to filter damaged red blood cells and micro-organisms

More information

Disclosure Statement. Encapsulated Bacteria. Functions of the Spleen 10/25/2017. Pharmacist Learning Objectives

Disclosure Statement. Encapsulated Bacteria. Functions of the Spleen 10/25/2017. Pharmacist Learning Objectives Pharmacist Learning Objectives No Spleen? No Problem. A Review of Vaccinations Indicated for the Asplenic Patient SCSHP Fall Meeting October 26, 2017 Explain the rationale for vaccinations in Select the

More information

BCG vaccine and tuberculosis

BCG vaccine and tuberculosis PART 2: Vaccination for special risk groups 2.1 Vaccination for Aboriginal and Torres Strait Islander people Aboriginal and Torres Strait Islander people historically had a very high burden of infectious

More information

Adult Pneumococcal Disease

Adult Pneumococcal Disease Adult Pneumococcal Disease Reviewed and updated July 2018 S. pneumoniae and pneumococcal disease The bacterium Streptococcus pneumoniae causes pneumococcal disease S. pneumoniae is commonly found in human

More information

MENINGITIS WHAT S NEW? 3 RD NOVEMBER 2018

MENINGITIS WHAT S NEW? 3 RD NOVEMBER 2018 MENINGITIS WHAT S NEW? 3 RD NOVEMBER 2018 CONFLICTS OF INTEREST Educational travel grant - Gilead JIM NEWCOMBE FRCPA FRACP ID PHYSICIAN, ROYAL NORTH SHORE HOSPITAL, SYDNEY CLINICAL MICROBIOLOGIST, DOUGLASS

More information

Adult Pneumococcal Disease

Adult Pneumococcal Disease Adult Pneumococcal Disease S. pneumoniae and pneumococcal disease The bacterium Streptococcus pneumoniae causes pneumococcal disease S. pneumoniae is commonly found in human nasopharynx (nose and throat)

More information

31/10/2017 COI. Travel Vaccination Update. Outline. General Advice. Steffen graph: travel epi. Checklist. Current nil

31/10/2017 COI. Travel Vaccination Update. Outline. General Advice. Steffen graph: travel epi. Checklist. Current nil Travel Vaccination Update COI Current nil Nigel Crawford HealthEd, Brisbane October 2017 Historical pharmaceutical industry funding to my research institute (MCRI) for special risk and vaccine safety projects

More information

NUH Drugs and Therapeutics Committee Joint Formulary Group. NUH Antimicrobial Guidelines Committee. April January 2019

NUH Drugs and Therapeutics Committee Joint Formulary Group. NUH Antimicrobial Guidelines Committee. April January 2019 Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc.) Author: Contact Name and Job Title Directorate & Speciality Adults and Children Guidelines for Patients with Absent

More information

Pneumococcal: Disease & Vaccine

Pneumococcal: Disease & Vaccine Pneumococcal: Disease & Vaccine Wednesday 15 June 2016 Wednesday 28 June 2016 Start time in your state: 7:30pm = QLD, NSW, VIC, TAS, ACT 7:00pm = SA, NT 5:30pm = WA Your presenter tonight Angela Newbound,

More information

Splenectomy Vaccine Protocol PIDPIC

Splenectomy Vaccine Protocol PIDPIC Splenectomy Vaccine Protocol PIDPIC 6.24.14 Rationale Spleen clears encapsulated bacteria and infected erythrocytes Serves as one of the largest lymphoid tissues where B cells are educated against encapsulated

More information

Adult Pneumococcal Disease

Adult Pneumococcal Disease Adult Pneumococcal Disease S. pneumoniae and pneumococcal disease The bacterium Streptococcus pneumoniae causes pneumococcal disease S. pneumoniae is commonly found in human nasopharynx (nose and throat)

More information

Vaccine Description Administration Re-vaccination Pneumococcal Vaccines Prevnar 13 (PCV 13)

Vaccine Description Administration Re-vaccination Pneumococcal Vaccines Prevnar 13 (PCV 13) Guideline for the Vaccination of Patients with Splenic Injury Requiring Splenectomy or Splenic Embolization This guideline is written for individuals 12 years and older admitted to the Maine Medical Center

More information

Q21. Where can I find more information on meningococcal disease and vaccines?

Q21. Where can I find more information on meningococcal disease and vaccines? FREQUENTLY ASKED QUESTIONS This fact sheet provides responses to some common questions about meningococcal vaccines, focusing on quadrivalent meningococcal conjugate vaccines (4vMenCVs). More detailed

More information

GUIDELINES FOR THE PREVENTION OF SEPSIS IN PATIENTS WITH ASPLENIA OR FUNCTIONAL HYPOSPLENIA

GUIDELINES FOR THE PREVENTION OF SEPSIS IN PATIENTS WITH ASPLENIA OR FUNCTIONAL HYPOSPLENIA GUIDELINES FOR THE PREVENTION OF SEPSIS IN PATIENTS WITH ASPLENIA OR FUNCTIONAL HYPOSPLENIA Date: 19 th August 2015 Version number: 3.1 final Author: Dr Sarah Taylor / Dr Susan Laidlaw This paper has been

More information

Management of Patients with an Absent or Dysfunctional Spleen

Management of Patients with an Absent or Dysfunctional Spleen Management of Patients with an Absent or Dysfunctional Spleen Author: Responsible Lead Executive Director: Endorsing Body: Governance or Assurance Committee: Health Protection Team Director of Public Health

More information

Adults and Children Guidelines Summary

Adults and Children Guidelines Summary Adults and Children Guidelines Summary For patients with absent or dysfunctional spleen. November 2008 Guidelines will not apply to every patient. Discretion should be exerted to modify them accordingly.

More information

Guidelines for the prevention and empiric therapy of bacterial infections for children with asplenia and hyposplenia

Guidelines for the prevention and empiric therapy of bacterial infections for children with asplenia and hyposplenia Atlantic Provinces Pediatric Hematology/Oncology Network Réseau d Oncologie et Hématologie Pédiatrique des Provinces Atlantiques 5850/5980 University Avenue, PO Box 9700, Halifax, NS, B3K 6R8, 1.902.470.7429,

More information

Preventing and treating infections in children with asplenia or hyposplenia

Preventing and treating infections in children with asplenia or hyposplenia Preventing and treating infections in children with asplenia or hyposplenia Marina I Salvadori, Victoria E Price; Canadian Paediatric Society Infectious Diseases and Immunization Committee Paediatr Child

More information

Update on Paediatric Influenza

Update on Paediatric Influenza Update on Paediatric Influenza ISG Annual Scientific Meeting 3 & 4 February 2018 Dr Margie Danchin Paediatrician, Department of General Medicine, RCH Senior Research Fellow, Vaccine and Immunisation Research

More information

See Spot Run Meningococcal update 2017

See Spot Run Meningococcal update 2017 See Spot Run Meningococcal update 2017 Jim Buttery Infection and Immunity Monash Children s Hospital Monash Health Monash University SAEFVIC How serious a disease is N meningitidis? Meningococcal disease

More information

Meningococci and meningococcal disease

Meningococci and meningococcal disease Australian Technical Advisory Group on Immunisation (ATAGI) Statement Advice for immunisation providers regarding the use of Bexsero a recombinant multicomponent meningococcal B vaccine (4CMenB) March

More information

Streptococcus pneumoniae CDC

Streptococcus pneumoniae CDC Streptococcus pneumoniae CDC Pneumococcal Disease Infection caused by the bacteria, Streptococcus pneumoniae» otitis media 20 million office visits (28-55% Strep)» pneumonia 175,000 cases annually» meningitis

More information

A guide for people without a fully working spleen

A guide for people without a fully working spleen A guide for people without a fully working spleen Some people are born without a spleen, or their spleen does not work properly. Some people may also need to have their spleen removed (splenectomy) as

More information

Background Rationale of resource Please note:

Background Rationale of resource Please note: Background In 2010, the Joint Committee on Vaccination and Immunisation (JCVI) convened a meningococcal subcommittee to conduct a comprehensive and detailed assessment of the evidence on the meningococcal

More information

Meningococcal Disease and College Students

Meningococcal Disease and College Students MASSACHUSETTS PUBLIC HEALTH FACT SHEET Meningococcal Disease and College Students May 2018 Page 1 of 4 What is meningococcal disease? Meningococcal disease is caused by infection with bacteria called Neisseria

More information

Quick Reference Guide CAT4. Adult Immunisation

Quick Reference Guide CAT4. Adult Immunisation Quick Reference Guide CAT4 Adult Immunisation - June 2015 Organisation Contacts Sydney Office Pen CS Level 1, 35 Moore St LEICHHARDT NSW 2040 Phone: + 61 (0) 2 9506 3200 Fax: +61 (0) 2 9566 1182

More information

This leaflet answers some common questions about PNEUMOVAX 23 (pronounced new-mo-vax). It does not contain all the available information.

This leaflet answers some common questions about PNEUMOVAX 23 (pronounced new-mo-vax). It does not contain all the available information. PNEUMOVAX 23 Pneumococcal Vaccine Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about PNEUMOVAX 23 (pronounced new-mo-vax). It does not contain all the

More information

Pneumococcal vaccination in UK: an update. Dr Richard Pebody Immunisation Department Health Protection Agency Centre for Infections

Pneumococcal vaccination in UK: an update. Dr Richard Pebody Immunisation Department Health Protection Agency Centre for Infections Pneumococcal vaccination in UK: an update Dr Richard Pebody Immunisation Department Health Protection Agency Centre for Infections Leading infectious causes of mortality, 2000 WHO estimates 3.5 Deaths

More information

CARE OF THE PEDIATRIC ASPLENIC PATIENT. Michael Siegenthaler, MD and Nadine Khouzam, MD

CARE OF THE PEDIATRIC ASPLENIC PATIENT. Michael Siegenthaler, MD and Nadine Khouzam, MD CARE OF THE PEDIATRIC ASPLENIC PATIENT Michael Siegenthaler, MD and Nadine Khouzam, MD CASE OVERVIEW 11-year-old Arabic speaking female who recently immigrated from Jordan presented to the office as a

More information

2/16/2015 IMMUNIZATION UPDATE Kelly Ridgway, RPh February 21, Today s Overview NEW RECOMMENDATIONS

2/16/2015 IMMUNIZATION UPDATE Kelly Ridgway, RPh February 21, Today s Overview NEW RECOMMENDATIONS IMMUNIZATION UPDATE 2015 Kelly Ridgway, RPh February 21, 2015 Today s Overview 1 2 3 4 5 6 Pneumococcal Vaccine Recommendations Meningococcal Vaccine Recommendations HPV Vaccine Recommendations Patient

More information

EPIREVIEW INVASIVE PNEUMOCOCCAL DISEASE, NSW, 2002

EPIREVIEW INVASIVE PNEUMOCOCCAL DISEASE, NSW, 2002 EPIREVIEW INVASIVE PNEUMOCOCCAL DISEASE, NSW, 2002 Robyn Gilmour Communicable Diseases Branch NSW Department of Health BACKGROUND Infection with the bacterium Streptococcus pneumoniae is a major cause

More information

2017 Vaccination Update

2017 Vaccination Update 2017 Vaccination Update NATHAN BOONSTRA, MD General Pediatrician, Blank Pediatric Clinic TODAY S OBJECTIVES Review the latest recommendations for immunizations, including HPV Meningococcal vaccines Influenza

More information

Introduction of a meningococcal ACWY immunisation programme for adolescents

Introduction of a meningococcal ACWY immunisation programme for adolescents Introduction of a meningococcal ACWY immunisation programme for adolescents Information for registered healthcare practitioners Acknowledgement: This resource has been adapted with the permission of Public

More information

Haemophilus influenzae

Haemophilus influenzae Haemophilus influenzae type b Severe bacterial infection, particularly among infants During late 19th century believed to cause influenza Immunology and microbiology clarified in 1930s Haemophilus influenzae

More information

16 November 2017 National Immunisation Advisory Committee Recommendations for the 2017/2018 Influenza Vaccination Campaign

16 November 2017 National Immunisation Advisory Committee Recommendations for the 2017/2018 Influenza Vaccination Campaign 16 November 2017 National Immunisation Advisory Committee Recommendations for the 2017/2018 Influenza Vaccination Campaign Please note the National Immunisation Advisory Committee (NIAC) has updated the

More information

Table 1 23 Pneumococcal Capsular Types Included in PNEUMOVAX 23

Table 1 23 Pneumococcal Capsular Types Included in PNEUMOVAX 23 PRODUCT INFORMATION NAME OF THE MEDICINE: PNEUMOVAX 23 (pneumococcal vaccine, polyvalent, MSD) DESCRIPTION: PNEUMOVAX 23 (Pneumococcal Vaccine, Polyvalent, MSD), is a sterile, liquid vaccine for intramuscular

More information

Vaccination Update. Pregnancy. 24-May-17. Disclosures. Overview. Paul Van Buynder Professor, Griffith University Chairman, Immunisation Coalition

Vaccination Update. Pregnancy. 24-May-17. Disclosures. Overview. Paul Van Buynder Professor, Griffith University Chairman, Immunisation Coalition Vaccination Update Paul Van Buynder Professor, Griffith University Chairman, Immunisation Coalition Disclosures I have been involved in vaccine studies funded by CSL, Sanofi Pasteur, Merck and Novartis

More information

Pneumococcal Disease and Pneumococcal Vaccines

Pneumococcal Disease and Pneumococcal Vaccines Pneumococcal Disease and Epidemiology and Prevention of - Preventable Diseases Note to presenters: Images of vaccine-preventable diseases are available from the Immunization Action Coalition website at

More information

CONJUGATE MENINGOCOCCAL (ACWY) VACCINE

CONJUGATE MENINGOCOCCAL (ACWY) VACCINE Cumbria & Lancashire Vaccine PGD Group ADVISORY INFORMATION FOR USE WITH PATIENT SPECIFIC DIRECTION OR INDIVIDUAL PRESCRIPTION SIGNED BY GP OR NON-MEDICAL PRESCRIBER. CONJUGATE MENINGOCOCCAL (ACWY) VACCINE

More information

Alberta Health and Wellness Public Health Notifiable Disease Management Guidelines August Pneumococcal Disease, Invasive (IPD)

Alberta Health and Wellness Public Health Notifiable Disease Management Guidelines August Pneumococcal Disease, Invasive (IPD) August 2011 Pneumococcal Disease, Invasive (IPD) Revision Dates Case Definition Reporting Requirements Remainder of the Guideline (i.e., Etiology to References sections inclusive) Case Definition August

More information

Change history Version number Change details Date Updated for National ACWY programme to be implemented August June 2015.

Change history Version number Change details Date Updated for National ACWY programme to be implemented August June 2015. Patient Group Direction for Conjugate Meningococcal ACWY vaccine Version: MEN ACWY CONJUGATE 2015.1 Start 1 st August 2015 Expiry 31 st July 2018 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING

More information

Invasive Bacterial Disease

Invasive Bacterial Disease Invasive Bacterial Disease Neisseria meningitidis, Haemophilus influenzae, and Group B Streptococcus (Streptococcus agalactiae) Case Report Form Electronic Disease Surveillance System Division of Surveillance

More information

Maternal immunisation and infant immunisation: core business for GPs What s new in 2017?

Maternal immunisation and infant immunisation: core business for GPs What s new in 2017? Maternal immunisation and infant immunisation: core business for GPs What s new in 2017? Peter McIntyre Director, National Centre for Immunisation Research & Surveillance Senior Staff Specialist, Children

More information

Vaccinations for Adults

Vaccinations for Adults Case: Vaccinations for Adults Lisa Winston, MD University of California, San Francisco San Francisco General Hospital A 30-year old healthy woman comes for a routine visit. She is recently married and

More information

Chapter 16 Pneumococcal Infection. Pneumococcal Infection. August 2015

Chapter 16 Pneumococcal Infection. Pneumococcal Infection. August 2015 Chapter 16 16 PPV introduced for at risk 1996 PCV7 introduced for at risk 2002 and as routine 2008 PCV13 replaced PCV7 in 2010 NOTIFIABLE In some circumstances, advice in these guidelines may differ from

More information

Flu & Pneumonia Provider Toolkit

Flu & Pneumonia Provider Toolkit Flu & Pneumonia Provider Toolkit 2018-2019 ILQI1809.1 Molina Healthcare and Providers Work Together to Protect Members from Flu & Pneumonia Molina Healthcare of Illinois (Molina) is continuing efforts

More information

4/7/13. Vaccinations for Adults and Adolescents. Effect of Full Use of Adult Immunizations. General Vaccine Information

4/7/13. Vaccinations for Adults and Adolescents. Effect of Full Use of Adult Immunizations. General Vaccine Information Vaccinations for Adults and Adolescents Nicholas A. Daniels, MD MPH Department of Medicine Professor of Clinical Medicine Declaration of full disclosure: No conflict of interest 2 Effect of Full Use of

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Management of meningitis and meningococcal disease in children and young people in primary and secondary care. 1.1 Short title

More information

AUSTRALIAN INFLUENZA SURVEILLANCE SUMMARY REPORT

AUSTRALIAN INFLUENZA SURVEILLANCE SUMMARY REPORT AUSTRALIAN INFLUENZA SURVEILLANCE SUMMARY REPORT No.19, 29, REPORTING PERIOD: 12 September 29 18 September 29 Key Indicators The counting of every case of pandemic influenza is no longer feasible in the

More information

Immunisation schedule Victoria

Immunisation schedule Victoria Infants and children July 2018 Birth H-B-Vax-II Paediatric or Paediatric 2 months (from 6 weeks) and 4 months Diphtheria-tetanus-pertussis, poliomyelitis-hepatitis B- Haemophilus influenzae type b Anterolateral

More information

Splenectomy Procedure Information

Splenectomy Procedure Information Where is the spleen located? Splenectomy Procedure Information Your spleen is located in the upper left side of the abdomen, partly protected by your lower ribs. It lies beneath the diaphragm; near the

More information

New NSW Immunisation Schedule

New NSW Immunisation Schedule New NSW Immunisation Schedule GP Update Prepared by Kym Bush Immunisation Coordinator Public Health Unit July 2018 Rationale for changes on 1 July 2018 Increase in cases of IPD in kiddies > 12 months Increase

More information

Bacterial diseases caused by Streptoccus pneumoniae in children

Bacterial diseases caused by Streptoccus pneumoniae in children Bacterial diseases caused by Streptoccus pneumoniae in children Bactermia 85% Bacterial pneumonia 66% Bacterial meningitis 50% Otitis media 40% Paranasal sinusitis 40% 0% 10% 20% 30% 40% 50% 60% 70% 80%

More information

National Immunisation News

National Immunisation News National Immunisation News The newsletter of the HSE National Immunisation Office July 2016 Changes to the Primary Childhood Immunisation Programme The National Immunisation Advisory Committee (NIAC) has

More information

BCHOOSE TO VACCINATED. Ask your doctor about the MenB * vaccine.

BCHOOSE TO VACCINATED. Ask your doctor about the MenB * vaccine. BCHOOSE TO VACCINATED Vaccinate against meningococcal disease caused by Neisseria meningitidis group B strains (MenB) with BEXSERO BEXSERO multicomponent meningococcal B vaccine (recombinant, adsorbed)

More information

Update on Adult Immunization Strategies: Understanding the Current Recommendations

Update on Adult Immunization Strategies: Understanding the Current Recommendations Update on Adult Immunization Strategies: Understanding the Current Recommendations EDWARD A. DOMINGUEZ, MD, FACP, FIDSA Medical Director, Organ Transplant Infectious Diseases Methodist Dallas Medical Center,

More information

Rationale for recommendations

Rationale for recommendations Australian Technical Advisory Group on Immunisation (ATAGI) Statement Clinical advice for immunisation providers on resumption of the use of 2010 trivalent seasonal vaccines in children less than 5 years

More information

Background In 2010, the Joint Committee on Vaccination and Immunisation (JCVI) convened a meningococcal subcommittee to conduct a comprehensive and

Background In 2010, the Joint Committee on Vaccination and Immunisation (JCVI) convened a meningococcal subcommittee to conduct a comprehensive and Background In 2010, the Joint Committee on Vaccination and Immunisation (JCVI) convened a meningococcal subcommittee to conduct a comprehensive and detailed assessment of the evidence on the meningococcal

More information

NSW Annual Vaccine-Preventable Disease Report, 2009

NSW Annual Vaccine-Preventable Disease Report, 2009 NSW Annual Vaccine-Preventable Disease Report, 29 Paula J. Spokes A,B and Robin E. Gilmour A A Communicable Diseases Branch, NSW Department of Health B Corresponding author. Email: pspok@doh.health.nsw.gov.au

More information

In February 2015, the Joint Committee on Vaccination and Immunisation (JCVI) *

In February 2015, the Joint Committee on Vaccination and Immunisation (JCVI) * Background In 2015, Public Health England (PHE) reported a continued increase in meningococcal serogroup W cases in England. The rise was initially recorded in 2009 and since this time, cases have steadily

More information

5/14/2015. Meagan Burns, MPH Massachusetts Adult Immunization Conference April relevant conflict. Grant Research/Support

5/14/2015. Meagan Burns, MPH Massachusetts Adult Immunization Conference April relevant conflict. Grant Research/Support Meagan Burns, MPH Massachusetts Adult Immunization Conference April 2015 Consultant Grant Research/Support Speaker s Bureau Major Stockholder Other Financial or Material Interest Off Label Use of Vaccines

More information

NHS Greater Glasgow & Clyde SOP No. BMT Haemopoietic Stem Cell Transplantation Services Vaccination Policy

NHS Greater Glasgow & Clyde SOP No. BMT Haemopoietic Stem Cell Transplantation Services Vaccination Policy This policy was written with advice from Dr S Ahmed, Consultant in Public Health, Greater Glasgow & Clyde. We would like to thank him for his guidance. 1. Background It is recommended by EBMT and CDC that

More information

Outsourcing in Clinical Trials 1-2 July 2015

Outsourcing in Clinical Trials 1-2 July 2015 Outsourcing in Clinical Trials 1-2 July 2015 Innovating Dr Chris Bailey Babraham Research Campus Babraham Cambridge CB22 3AT UK +44 (0)1223 496115 Vaccines www.immbio.com 1 Utilising Academia for the Benefit

More information

9/12/2018. Meningococcal Disease and Meningococcal Vaccine. Neisseria meningitidis. Meningococcal Disease Pathogenesis. Aerobic gram-negative bacteria

9/12/2018. Meningococcal Disease and Meningococcal Vaccine. Neisseria meningitidis. Meningococcal Disease Pathogenesis. Aerobic gram-negative bacteria Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Meningococcal Disease and Meningococcal Vaccine Adult Track Chapter 14 Photographs and images included

More information

WHAT S NEW WITH VACCINATIONS IN 2016?

WHAT S NEW WITH VACCINATIONS IN 2016? WHAT S NEW WITH VACCINATIONS IN 2016? MenB and a Few Other Changes Lynn Bahta, RN, PHN Immunization Clinical Consultant Minnesota Department of Health May 2016 Disclosure No conflict of interest Will discuss

More information

Communicable Disease Update; Vol. 16 (1), February 2017

Communicable Disease Update; Vol. 16 (1), February 2017 Communicable Disease Update; Vol. 16 (1), February 017 Item Type Other Authors Health Service Executive (HSE) South (South East), Department of Public Health Publisher Health Service Executive (HSE) South

More information

INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND

INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND A REPORT BY THE HEALTH PROTECTION SURVEILLANCE CENTRE IN COLLABORATION WITH THE IRISH MENINGITIS

More information

Meningococcal Disease a resurgence of an old foe?

Meningococcal Disease a resurgence of an old foe? Meningococcal Disease a resurgence of an old foe? To talk about NZ rates of meningococcal disease Changing serotypes Clinical presentations Meningococcal vaccines What is meningococcal disease? Important

More information

BabyJabs Vaccines. All vaccines are mercury-free We use aluminium-free vaccines wherever possible

BabyJabs Vaccines. All vaccines are mercury-free We use aluminium-free vaccines wherever possible BabyJabs Vaccines All vaccines are mercury-free We use aluminium-free vaccines wherever possible BabyJabs is a dedicated children s immunisation service, offering a choice of single and small combination

More information

INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND

INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND A REPORT BY THE HEALTH PROTECTION SURVEILLANCE CENTRE IN COLLABORATION WITH THE IRISH MENINGITIS

More information

INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND

INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND A REPORT BY THE HEALTH PROTECTION SURVEILLANCE CENTRE IN COLLABORATION WITH THE IRISH MENINGITIS

More information

Outline. Summary of 2017 season; vaccine coverage and effectiveness. Influenza A/H3 vaccine problems season new vaccines and programs

Outline. Summary of 2017 season; vaccine coverage and effectiveness. Influenza A/H3 vaccine problems season new vaccines and programs Influenza Allen Cheng Professor of Infectious Diseases Epidemiology, Monash University Director, Infection Prevention and Healthcare Epidemiology Unit, Alfred Health Outline Summary of 2017 season; vaccine

More information

INVASIVE MENINGOCOCCAL DISEASE (IMD), OTHER BACTERIAL MENINGITIS, HAEMOPHILUS INFLUENZAE & VIRAL MENINGITIS INFECTIONS IN IRELAND

INVASIVE MENINGOCOCCAL DISEASE (IMD), OTHER BACTERIAL MENINGITIS, HAEMOPHILUS INFLUENZAE & VIRAL MENINGITIS INFECTIONS IN IRELAND INVASIVE MENINGOCOCCAL DISEASE (IMD), OTHER BACTERIAL MENINGITIS, HAEMOPHILUS INFLUENZAE & VIRAL MENINGITIS INFECTIONS IN IRELAND A REPORT BY THE HEALTH PROTECTION SURVEILLANCE CENTRE (HPSC) IN COLLABORATION

More information

2017 Vaccine Preventable Disease Summary

2017 Vaccine Preventable Disease Summary 2017 Vaccine Preventable Disease Summary Prepared 12251 James Street Holland, MI 49424 www.miottawa.org/healthdata October 2018 2017 Summary of Vaccine Preventable Diseases in Ottawa County This is a detailed

More information

Vaccines in Immunocompromised hosts

Vaccines in Immunocompromised hosts Vaccines in Immunocompromised hosts Carlos del Rio, MD Emory Center for AIDS Research October 2013 Immunocompromised hosts Number has increased rapidly in the past decades Broad term that encompasses different

More information

BabyJabs Vaccines. All vaccines are mercury- free We use aluminium- free vaccines wherever possible

BabyJabs Vaccines. All vaccines are mercury- free We use aluminium- free vaccines wherever possible BabyJabs Vaccines All vaccines are mercury- free We use aluminium- free vaccines wherever possible BabyJabs is a dedicated children s immunisation service, offering a choice of single and small combination

More information

Annual Epidemiological Report

Annual Epidemiological Report August 2018 Annual Epidemiological Report Key Facts Streptococcus 1Pneumoniae (invasive) in Ireland, 2017 In 2017, 415 confirmed cases of invasive pneumococcal diseases (IPD) were reported in Ireland,

More information

If you have any concerns about being given this vaccine, ask your doctor or pharmacist.

If you have any concerns about being given this vaccine, ask your doctor or pharmacist. PNEUMOVAX 23 Pneumococcal Vaccine Single Dose Vial/Pre-filled Syringe What is in this leaflet This leaflet answers some common questions about PNEUMOVAX 23. It does not contain all the available information.

More information

Recommended Immunization Schedules for Persons Aged 0 Through 18 Years UNITED STATES, 2016

Recommended Immunization Schedules for Persons Aged 0 Through 18 Years UNITED STATES, 2016 Recommended Immunization Schedules for Persons Aged 0 Through 18 Years UNITED STATES, 2016 This schedule includes recommendations in effect as of January 1, 2016. Any dose not administered at the recommended

More information

Influenza VE studies in Australia

Influenza VE studies in Australia Influenza VE studies in Australia Heath Kelly Head, Epidemiology Unit, Victorian Infectious Diseases Reference Laboratory Adjunct Professor, National Centre for Epidemiology and Population Health, Australian

More information

HIT ME WITH YOUR BEST SHOT: UPDATE ON IMMUNIZATIONS. Karen Hoang, PharmD Clinical Pharmacy Specialist, MTM Services UPMC Health Plan

HIT ME WITH YOUR BEST SHOT: UPDATE ON IMMUNIZATIONS. Karen Hoang, PharmD Clinical Pharmacy Specialist, MTM Services UPMC Health Plan HIT ME WITH YOUR BEST SHOT: UPDATE ON IMMUNIZATIONS Karen Hoang, PharmD Clinical Pharmacy Specialist, MTM Services UPMC Health Plan DISCLOSURES No financial or other conflicts to disclose LEARNING OBJECTIVES

More information

INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND

INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND A REPORT BY THE HEALTH PROTECTION SURVEILLANCE CENTRE IN COLLABORATION WITH THE IRISH MENINGITIS

More information

The National Immunisation Schedule Update and Current issues. Dr Brenda Corcoran National Immunisation Office.

The National Immunisation Schedule Update and Current issues. Dr Brenda Corcoran National Immunisation Office. The National Immunisation Schedule Update and Current issues Dr Brenda Corcoran National Immunisation Office Objectives To outline immunisation schedules in Ireland Primary childhood schedule Vaccine uptake

More information

3 rd dose. 3 rd or 4 th dose, see footnote 5. see footnote 13. for certain high-risk groups

3 rd dose. 3 rd or 4 th dose, see footnote 5. see footnote 13. for certain high-risk groups Figure 1. Recommended immunization schedule for persons aged 0 through 18 years 2013. (FOR THOSE WHO FALL BEHIND OR START LATE, SEE THE CATCH-UP SCHEDULE [FIGURE 2]). These recommendations must be read

More information

NeisVac-C Meningococcal group C polysaccharide conjugate vaccine (tetanus toxoid protein conjugate)

NeisVac-C Meningococcal group C polysaccharide conjugate vaccine (tetanus toxoid protein conjugate) NeisVac-C Meningococcal group C polysaccharide conjugate vaccine (tetanus toxoid protein conjugate) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about

More information

Influenza Surveillance to Inform Decision Making

Influenza Surveillance to Inform Decision Making Influenza Surveillance to Inform Decision Making Ms Kate Pennington Epidemiologist Assistant Director, Vaccine Preventable Diseases Surveillance Office of Health Protection Department of Health and Ageing

More information

Adult Vaccine Update. NB Internal Medicine Update, April 22 nd, 2016 Dan Smyth, MD, FRCPC, DTMH

Adult Vaccine Update. NB Internal Medicine Update, April 22 nd, 2016 Dan Smyth, MD, FRCPC, DTMH Adult Vaccine Update NB Internal Medicine Update, April 22 nd, 2016 Dan Smyth, MD, FRCPC, DTMH Summary points: Canadian adults > 18 should be regularly assessed to ensure recommended vaccinations are up

More information

Immunisation Update for Occupational Health

Immunisation Update for Occupational Health Immunisation Update for Occupational Health Dr Gayatri Amirthalingam Immunisation, Hepatitis & Blood Safety department Public Health England 29 th April 2016 Session Outline Epidemiology of vaccine preventable

More information

Postsplenectomy Syndrome Topic Review May 22, Done By: Sara AlArfaj, PharmD candidate KSU

Postsplenectomy Syndrome Topic Review May 22, Done By: Sara AlArfaj, PharmD candidate KSU Postsplenectomy Syndrome Topic Review May 22, 2014 Done By: Sara AlArfaj, PharmD candidate KSU Objectives Brief introduction about the spleen and it s role in the human body Identify splenectomy and it

More information

Current Immunisation Issues in the Nepean Blue Mountains Presented as part of the Immunisation Update education series in October 2017

Current Immunisation Issues in the Nepean Blue Mountains Presented as part of the Immunisation Update education series in October 2017 Current Immunisation Issues in the Nepean Blue Mountains 2017 Presented as part of the Immunisation Update education series in October 2017 Additional funded vaccines Catch up vaccines for all individuals

More information

2018 Immunisation Update

2018 Immunisation Update 2018 Immunisation Update A puzzling time?!! Sometimes the hardest pieces of a puzzle to assemble, are the ones missing from the box. Dixie Waters, Author Authority to Immunise NSW Immunisation Schedule

More information

Pneumococcal Vaccine in Children: current situation

Pneumococcal Vaccine in Children: current situation Pneumococcal Vaccine in Children: current situation LAU Yu Lung Chair Professor of Paediatrics Doris Zimmern Professor in Community Child Health LKS Faculty of Medicine, The University of Hong Kong Chairman

More information

PNEUMOVAX 23 pneumococcal vaccine, polyvalent solution for injection

PNEUMOVAX 23 pneumococcal vaccine, polyvalent solution for injection PRODUCT INFORMATION PNEUMOVAX 23 pneumococcal vaccine, polyvalent solution for injection NAME OF THE MEDICINE PNEUMOVAX 23 (pneumococcal vaccine, polyvalent) DESCRIPTION PNEUMOVAX 23 (Pneumococcal Vaccine

More information

Revisions to Communicable Disease Control Manual: Chapter 2 Immunization Program

Revisions to Communicable Disease Control Manual: Chapter 2 Immunization Program January 5, 2010 ATTN: Medical Health Officers and Branch Offices Public Health Nursing Administrators and Assistant Administrators Holders of Communicable Disease Control Manuals Re: Revisions to Communicable

More information

Changes to the meningococcal C conjugate (MenC) vaccine schedule 2014 first-time university entrants under the age of 25

Changes to the meningococcal C conjugate (MenC) vaccine schedule 2014 first-time university entrants under the age of 25 Changes to the meningococcal C conjugate (MenC) vaccine schedule 2014 first-time university entrants under the age of 25 An update for registered healthcare practitioners August 2014 Quality Education

More information